Lidocaine Hci Injection, Solution
Product Images NDC 51662-1384
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Maximum Recommended Dosages (Maximum Recommended Dosage)
Pouch 1
Precautions (Precautions)
Rfid 1
Serialized Labeling (Serialized Labeling)
Logo (Spl Unclassified Logo)
Structure (Structure)
Vial 1
NDC 0143-9575-01 is a Lidocaine HCI Injection, USP of strength (1,000mg/50mL). It is meant for infiltration and nerve block but NOT for epidural or caudal use. It contains Methyiparaben as a Preservative. Each vial is sterile, non-pyrogenic, and contains Lidocaine HC1 20 mg, sodium chloride, mp, metiypacaen 1 g, sodium rosde, and/or ytrochon aid to i 105010 7.0. The suggested dosage is given in the insert. The solution should not be used if discolored or containing a precipitate. It needs to be stored at 20t 25° (68" 1 77°F). This product is distributed by ema Elolown, 07724 Ush.*
Vial Labeling (Vial Labeling)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.